Back
Amicus Therapeutics Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
47
FOLD
Amicus Therapeutics
Last Price:
$9.78
Seasonality Move:
5.47%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
The current trend is relatively stagnant and FOLD is experiencing slight buying pressure.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.79 | Sell |
| 20-day SMA: | 9.85 | Sell |
| 50-day SMA: | 10.42 | Sell |
| 200-day SMA: | 10.6 | Sell |
| 8-day EMA: | 9.79 | Sell |
| 20-day EMA: | 9.88 | Sell |
| 50-day EMA: | 10.2 | Sell |
| 200-day EMA: | 10.78 | Sell |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 45.33 | Sell |
| Chaikin Money Flow: | 335895 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.62 - 10) | Sell |
| Bollinger Bands (100): | (9.96 - 11.54) | Sell |
Amicus Therapeutics Technical Analysis
| Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 9.77 while FOLD 8-day simple moving average is 9.79, which is a Sell signal.
-
The stock price of FOLD is 9.77 while Amicus Therapeutics 20-day SMA is 9.85, which makes it a Sell.
-
Amicus Therapeutics 50-day simple moving average is 10.42 while FOLD share price is 9.77, making it a Sell technically.
-
FOLD stock price is 9.77 and Amicus Therapeutics 200-day simple moving average is 10.60, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Sell
47
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a SellThe current Amicus Therapeutics [FOLD] share price is $9.77. The Score for FOLD is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
2.9B
Price in USD:
9.77
Share Volume:
1.1M
Amicus Therapeutics 52-Week Range
52-Week High:
14.57
52-Week Low:
9.02
Sell
47
Amicus Therapeutics (FOLD)
is a Sell
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?The Amicus Therapeutics stock price is 9.77 USD today.
-
Will FOLD stock go up or go down?Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Amicus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is overvalued.
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 9.77 while FOLD 8-day exponential moving average is 9.79, which is a Sell signal.
-
The stock price of FOLD is 9.77 while Amicus Therapeutics 20-day EMA is 9.88, which makes it a Sell.
-
Amicus Therapeutics 50-day exponential moving average is 10.20 while FOLD share price is 9.77, making it a Sell technically.
-
FOLD stock price is 9.77 and Amicus Therapeutics 200-day simple moving average is 10.78, creating a Sell signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.19 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
-
FOLD Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Amicus Therapeutics is a Sell
-
Amicus Therapeutics Relative Strength Index (RSI) is 45.33, which suggest Amicus Therapeutics is oversold
-
The Bollinger Bands (25) for Amicus Therapeutics is (9.62 - 10), which suggest Amicus Therapeutics is a Sell
-
The Bollinger Bands (100) for Amicus Therapeutics is (9.96 - 11.54), which suggest Amicus Therapeutics is a Sell
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.